{
  "data": [
    {
      "question": "What is the purpose of designing Zn-QCDM?",
      "answer": "The purpose of designing Zn-QCDM is for targeted drug delivery to the nucleus for cancer therapy.",
      "difficulty": "easy",
      "type": "factual"
    },
    {
      "question": "What method was used to determine the structure of Zn-QCDM?",
      "answer": "The structure of Zn-QCDM was determined by NMR, HR-MS, and single-crystal X-ray diffraction.",
      "difficulty": "medium",
      "type": "factual"
    },
    {
      "question": "How does Zn-QCDM target the nucleus?",
      "answer": "Zn-QCDM targets the nucleus through strong π-π stacking and Zn-O coordination with unpaired bases on RNA.",
      "difficulty": "hard",
      "type": "reasoning"
    },
    {
      "question": "What is the emission wavelength of Zn-QCDM?",
      "answer": "The emission wavelength of Zn-QCDM is 618 nm.",
      "difficulty": "medium",
      "type": "factual"
    },
    {
      "question": "What is the drug loading capacity of Zn-QCDM for CPT at a mass ratio of 1:2?",
      "answer": "The drug loading capacity of Zn-QCDM for CPT at a mass ratio of 1:2 is 131%.",
      "difficulty": "hard",
      "type": "factual"
    },
    {
      "question": "Does Zn-QCDM exhibit high or low cytotoxicity?",
      "answer": "Zn-QCDM exhibits low cytotoxicity and high biocompatibility.",
      "difficulty": "medium",
      "type": "reasoning"
    },
    {
      "question": "True or False: Zn-QCDM has a high photostability.",
      "answer": "True",
      "difficulty": "easy",
      "type": "True or False"
    },
    {
      "question": "True or False: The main endocytosis pathway of Zn-QCDM is macropinocytosis.",
      "answer": "False",
      "difficulty": "easy",
      "type": "True or False"
    },
    {
      "question": "What is the main advantage of using Zn-QCDM for drug delivery?",
      "answer": "The main advantage of using Zn-QCDM for drug delivery is its nucleus-targeting capability, which enhances the therapeutic effect of drugs.",
      "difficulty": "medium",
      "type": "reasoning"
    },
    {
      "question": "True or False: Zn-QCDM can be used for live cell imaging.",
      "answer": "True",
      "difficulty": "easy",
      "type": "True or False"
    },
    {
      "question": "What is the effect of Zn-QCDM on tumor growth in vivo?",
      "answer": "Zn-QCDM significantly inhibits tumor growth in vivo when used for CPT delivery.",
      "difficulty": "hard",
      "type": "reasoning"
    },
    {
      "question": "True or False: Zn-QCDM's drug delivery mechanism relies on importin α/β mediated nuclear transport.",
      "answer": "True",
      "difficulty": "medium",
      "type": "True or False"
    },
    {
      "question": "What is the role of Zn ions in Zn-QCDM?",
      "answer": "Zn ions in Zn-QCDM coordinate with the P=O bonds on DNA and RNA backbones and form stable π-π stacking interactions with RNA bases.",
      "difficulty": "hard",
      "type": "reasoning"
    },
    {
      "question": "True or False: Zn-QCDM has a reduced optical bandgap compared to the pristine QCDM.",
      "answer": "True",
      "difficulty": "medium",
      "type": "True or False"
    },
    {
      "question": "What is the significance of Zn-QCDM's photostability?",
      "answer": "The photostability of Zn-QCDM is significant for its application in bioimaging, optoelectronics, and other optical-related applications.",
      "difficulty": "medium",
      "type": "reasoning"
    },
    {
      "question": "True or False: Zn-QCDM's targeting efficiency for the nucleus is over 50%.",
      "answer": "False",
      "difficulty": "easy",
      "type": "True or False"
    },
    {
      "question": "What is the main acting organelle of Zn-HNDM in cell imaging?",
      "answer": "The main acting organelle of Zn-HNDM in cell imaging is the mitochondrion.",
      "difficulty": "medium",
      "type": "factual"
    },
    {
      "question": "True or False: Zn-QCDM's drug delivery mechanism involves energy-dependent clathrin-mediated endocytosis.",
      "answer": "True",
      "difficulty": "medium",
      "type": "True or False"
    },
    {
      "question": "What is the impact of Zn-QCDM on the therapeutic outcome of CPT?",
      "answer": "Zn-QCDM enhances the therapeutic outcome of CPT by effectively delivering the drug to the nucleus and significantly inhibiting tumor growth.",
      "difficulty": "hard",
      "type": "reasoning"
    },
    {
      "question": "True or False: Zn-QCDM can release CPT continuously and stably for over 54 hours.",
      "answer": "True",
      "difficulty": "medium",
      "type": "True or False"
    }
  ]
}
